C-reactive protein (CRP) in the prognosis of complications of parapneumonic effusions (PPE)

T. Pejcic, I. Stankovic, I. Djorjdevic, T. Radjenovic, D. Nastasijevic, Z. Ciric (Nis, Republic Of Serbia)

Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity
Session: The prognosis of community-acquired pneumonia: old and new markers of severity
Session type: E-Communication Session
Number: 2217
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Pejcic, I. Stankovic, I. Djorjdevic, T. Radjenovic, D. Nastasijevic, Z. Ciric (Nis, Republic Of Serbia). C-reactive protein (CRP) in the prognosis of complications of parapneumonic effusions (PPE). Eur Respir J 2010; 36: Suppl. 54, 2217

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum C-reactive protein levels predict the need for surgical intervention in patients with empyema/complicated parapneumonic pleural effusions
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019

Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP)
Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia
Year: 2007


C-reactive protein (CRP) utility in severe community-acquired pneumonia (SCAP) prognosis
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011


Biomarkers of infection for the differential diagnosis of pleural effusions
Source: Eur Respir J 2009; 34: 1383-1389
Year: 2009



D-dimer to C-reactive protein (CRP) ratio in patients with suspected pulmonary embolism
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010


Procalcitonin and CRP levels in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009

C-reactive protein (CRP) at admission: is it really usefull in COVID-19 pneumonia?
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Diagnostic value of C-reactive protein in discrimination between complicated and uncomplicated parapneumonic effusion
Source: International Congress 2019 – Clinical problems
Year: 2019


Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care
Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care
Year: 2008


Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions?
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012

Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP)
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016


The use of pleural fluid C-reactive protein level, as a diagnostic marker for pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


The investigation of diagnostic value of serum reactive protein (CRP) in patients with pleural effusion
Source: Eur Respir J 2006; 28: Suppl. 50, 374s
Year: 2006

An experience of discrimination of exudative pleural effusions based on C-reactive protein (CRP) and adenosine deaminase (ADA) in Belarus
Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives
Year: 2008


C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia
Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention
Year: 2008


Pleural fluid C-reactive protein concentration in discriminating uncomplicated from complicated parapneumonic pleural effusion
Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Year: 2012

The discriminatory value of procalcitonin (PCT) and C-reactive protein (CRP) levels in HIV-seropositive patients presenting with community acquired pneumonia (CAP) due to pulmonary tuberculosis (PTB) compared with patients with pneumococcal pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 241s
Year: 2004

The diagnostic value of pleural fluid C-reactive protein level in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 356s
Year: 2002

Correlation between pleural fluid and serum C-reactive protein in patients with pleural effusion due to different etiologies
Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician
Year: 2020